Study of IG3018 for high uric acid with or without kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new medicine, IG3018, to lower high uric acid levels in people with or without chronic kidney disease. It aims to find the right dose and see if it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have high uric acid (measured in blood, typically above a certain level).
- Your kidney function is stable, and you either have healthy kidneys or Stage 3a-4 chronic kidney disease (not on dialysis).
- You have not had gout flares requiring treatment in the last month.
- You can stop other urate-lowering medicines (like allopurinol) for the study.
- You are not pregnant or planning pregnancy, and you use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, NNC4004-0002, for people who have high uric acid levels but no gout symptoms. The goal is to see if it is safe and how well it works in healthy adults aged 35 to 75.
This trial is looking for patients with chronic conditions like diabetes, high blood pressure, obesity, kidney disease, or heart disease to screen for high uric acid levels. It aims to understand how common this is and find better ways to manage it.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
This study tests if a new drug, ABP-671, can safely lower high uric acid levels in people with chronic kidney disease. It may help reduce gout attacks and kidney damage.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
Hear when a new Hyperuricemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.